Sahlgrenska Cardiomyopathy Project

Göteborg University

Status: Invitation-only

Conditions: Myocarditis; Dilated Cardiomyopathies; Amyloidosis; Heart (Manifestation); Arrhythmogenic Right Ventricular Cardiomyopathy; Restrictive Cardiomyopathy; Sarcoidosis With Myocarditis; Hypertrophic Cardiomyopathy; Giant Cell Myocarditis

Study type: Observational

Funder types: Other

Identifiers

NCT03527342

SUCARD

Details and patient eligibility

About

This is a joint project by Sahlgrenska University Hospital: Sahlgrenska, Östra and Mölndal.

Our objective is to diagnose and map patients with well phenotyped cardiomyopathies (CMP) including in depth clinical and molecular phenotyping to enable earlier and specific treatment. The project will serve as:

1. resource for diagnostic and therapeutic trials
2. common biomaterial bank
3. resource for detailed molecular analyses on patients' biomaterials and patient specific symptoms and examination results

Enrollment: 3,000 estimated patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with primary cardiomyopathies including hereditary and inflammatory dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, left ventricular non-compaction cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, myocarditis, giant cell myocarditis, sarcoidosis and amyloidosis engaging the heart

Exclusion criteria

• Patient with other preexisting cardiac diseases such as significant valvular, ischemic or pericardial disease before they receive a cardiomyopathy diagnose
• patients < 18 years

Trial design

3,000 participants in 8 patient groups

Dilated Cardiomyopathy

Myocarditis

Sarcoidosis Heart

Giant Cell Myocarditis

Amyloidosis Heart

Hypertrophic Cardiomyopathies

Left Ventricular Myocardial Noncompaction Cardiomyopathy

Arrhythmogenic Right Ventricular Cardiomyopathies